A network meta-analysis (NMA) further corroborates these findings, showing that DOPA clearly outperforms other imaging modalities in detecting recurrent MTC in both patient- and lesion-based analyses, regardless of serum Ctn or CEA levels, or Ctn doubling time (107). Here, CEACAM5 is linked to medullary thyroid gland carcinoma.